How do you fund drug development? In the last two years, we have seen a record number of biotechs go public, and their successful initial public offerings will provide the capital for their late-stage trials. But how did they get there?
Venture capital. It has long been the lifeblood for early-stage biotechs, and 70 percent of last year's IPOs were issued by VC-backed companies. Companies like mine need years of private investment before going public is even an option.
Image: http://www.freedigitalphotos.net
To read the original article: Bipartisan bill would help biotechs fund research
